"Immunoblotting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.
| Descriptor ID |
D015151
|
| MeSH Number(s) |
E05.478.566.320 E05.601.470.320
|
| Concept/Terms |
Immunoblotting, Reverse- Immunoblotting, Reverse
- Immunoblottings, Reverse
- Reverse Immunoblottings
- Reverse Immunoblotting
Immunoelectroblotting- Immunoelectroblotting
- Immunoelectroblottings
- Electroimmunoblotting
- Electroimmunoblottings
Dot Immunoblotting- Dot Immunoblotting
- Immunoblotting, Dot
- Dot Immunoblottings
- Immunoblottings, Dot
|
Below are MeSH descriptors whose meaning is more general than "Immunoblotting".
Below are MeSH descriptors whose meaning is more specific than "Immunoblotting".
This graph shows the total number of publications written about "Immunoblotting" by people in this website by year, and whether "Immunoblotting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 3 | 3 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoblotting" by people in Profiles.
-
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities. Osteoarthritis Cartilage. 2015 Sep; 23(9):1523-31.
-
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. PLoS One. 2014; 9(7):e102112.
-
The ryanodine receptor store-sensing gate controls Ca2+ waves and Ca2+-triggered arrhythmias. Nat Med. 2014 Feb; 20(2):184-92.
-
p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes. J Mol Cell Cardiol. 2014 Feb; 67:77-85.
-
Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction. PLoS One. 2013; 8(9):e75846.
-
Differential localization of neuregulin-1 type III in the central and peripheral nervous system. Brain Res. 2011 Jan 19; 1369:10-20.
-
Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology. 2010 Jul; 151(7):3026-37.
-
HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol. 2010 Mar; 11(3):265-72.
-
Expression profile of PTPIP51 in mouse brain. J Comp Neurol. 2009 Dec 20; 517(6):892-905.
-
Cataracts are caused by alterations of a critical N-terminal positive charge in connexin50. Invest Ophthalmol Vis Sci. 2008 Jun; 49(6):2549-56.